Obesity Clinical Trial
Official title:
First-in-man Trial of the Magnetic-controlled Balloon Inflation Mechanism of a Novel Ingestible Weightloss Microcapsule
The objective of this study is to demonstrate the ease of deployment of a novel magnetically-controlled ingestible weight loss microcapsule* and the functionality of the magnetically controlled inflation of the balloon within the stomach.
The objective of this study is to demonstrate the ease of deployment of a novel magnetically-controlled ingestible weight loss microcapsule and the functionality of the magnetically controlled inflation of the balloon within the stomach. Device comes in the form of a gelatine coated pill (Ø9.6mm x 27mm) . Once in the stomach, the device may be driven by external magnetic controllers which can control both its position and orientation. It allows flexible approach of the external magnetic fields in any axial directions of the device, and it also controls the inflation valve which controls the inflation of an attached balloon. The inflated balloon will partially fill up the stomach, giving the subject the feel of satiety to reduce his/her desire to eat more food. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Recruiting |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Recruiting |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT03714646 -
Beta Glucan and Acetate Production
|
N/A | |
| Recruiting |
NCT03255005 -
Endomina Controlled Study
|
N/A | |
| Enrolling by invitation |
NCT03063606 -
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
|
Phase 2/Phase 3 | |
| Completed |
NCT03317587 -
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
|
N/A | |
| Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
| Active, not recruiting |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
| Completed |
NCT02235961 -
Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT03195712 -
Metabolically Healthy Obesity: Correlations Between BMI and Metabolic Syndrome Biomarkers
|
N/A | |
| Completed |
NCT00341406 -
Fat Cell Size in Insulin Resistance
|
||
| Not yet recruiting |
NCT03470272 -
Effects of Red Light LED Therapy on Body Contouring
|
N/A | |
| Recruiting |
NCT03627104 -
Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity
|
N/A | |
| Recruiting |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
| Active, not recruiting |
NCT02918279 -
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
|
Phase 3 | |
| Completed |
NCT00494767 -
Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
|
Phase 1 | |
| Recruiting |
NCT03338296 -
Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years
|
Phase 4 |
